0443 GMT - Atlas Arteria was seen as a potential takeover target by Citi analyst Suraj Nebhani even before indications that a suitor could be positioning for a tilt at the toll-road operator. Nebhani tells clients in a note that he expects renewed speculation about a potential takeover following an Australian newspaper report that IFM Investors has increased its stake in Atlas Arteria to 32%. He points out that IFM has bid for Atlas Arteria in the past and sees interests as a positive for the ASX-listed stock. Citi has a buy rating and a A$5.22 target price on the stock, which is down 0.2% at A$5.21. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
May 19, 2025 00:43 ET (04:43 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.